Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators.
about
San-Huang-Xie-Xin-Tang Constituents Exert Drug-Drug Interaction of Mutual Reinforcement at Both Pharmacodynamics and Pharmacokinetic Level: A ReviewHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsAmelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathwayIn vitro anti-proliferative activity of Argemone gracilenta and identification of some active components.Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach.Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.Uncommon presentation of potential medication-related osteonecrosis of the jawBeneficial Effects of Berberine on Oxidized LDL-Induced Cytotoxicity to Human Retinal Müller Cells.Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer.Putative role of HIF transcriptional activity in melanocytes and melanoma biology.Natural products with therapeutic potential in melanoma metastasis.Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expression.Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo.Antiangiogenic Effect of Ethanol Extract of Vigna angularis via Inhibition of Phosphorylation of VEGFR2, Erk, and Akt.Alkaloids isolated from natural herbs as the anticancer agents.Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma.Sidestream dark field videomicroscopy for in vivo evaluation of vascularization and perfusion of mammary tumours in HER2/neu transgenic mice.
P2860
Q28075782-3708C107-DB98-4BEA-90DE-1283F90EBCF8Q28393898-CEB8820B-25B9-4BB1-81FE-782EF1E050D7Q28487645-8EB39E8C-F27E-4AB3-A277-8DADB161DC15Q35063884-4D71E497-7357-49ED-9685-24F7B1254899Q36123951-E7F1332E-90ED-4973-8A11-E7FD35768BE2Q36220497-5910BD5B-1883-4570-AB5C-52F945B501EDQ36624810-37EF06F8-5948-4AA9-8068-0650DF17E82CQ37126456-5AB4E749-1D5C-4922-BCF4-17220EC68E30Q37377316-CAAE8C00-819E-4E3E-A015-3F81D6308555Q38160223-7269AFD0-27A8-450F-8F84-C3C081728836Q38505151-79FA103D-B582-47D1-B11B-031C64EC83C3Q39044758-AB0EC735-1EE9-48F8-B2E9-FC4142B4CB22Q39097185-8743FBA5-47BD-43E3-956E-5010B6F38DE0Q41972162-938C9AAF-7D62-42DD-B4A8-4DD624A6D47BQ42324855-5F06863D-44DE-4043-8401-3C3586F5428EQ47677019-0BC0235A-366B-498B-BA46-A804D2379159Q47782870-0A2CF9F4-896E-48FE-B8F4-BA69D6AE1A4A
P2860
Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antiangiogenic activity of ber ...... and proinflammatory mediators.
@en
Antiangiogenic activity of ber ...... and proinflammatory mediators.
@nl
type
label
Antiangiogenic activity of ber ...... and proinflammatory mediators.
@en
Antiangiogenic activity of ber ...... and proinflammatory mediators.
@nl
prefLabel
Antiangiogenic activity of ber ...... and proinflammatory mediators.
@en
Antiangiogenic activity of ber ...... and proinflammatory mediators.
@nl
P2860
P1476
Antiangiogenic activity of ber ...... and proinflammatory mediators.
@en
P2093
Girija Kuttan
P2860
P356
10.3109/01480545.2011.589437
P577
2012-01-01T00:00:00Z